EPHA5 RS7349683 IS NOT ASSOCIATED WITH CIPN-SENSITIVITY IN LUNG CANCER PATIENTS RECEIVING PACLITAXEL TDM.
Clin Pharmacol Ther
2020
107 Suppl 1
S58-S58
Preanalytical variables that affect the outcome of cell-free DNA measurements.
Crit Rev Clin Lab Sci
2020
57
7
484-507
Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With CYP2C9 and VKORC1 Polymorphisms.
Front Pharmacol
2020
10
Biological variability of cell-free DNA in healthy females at rest within a short time course.
Int J Legal Med
2020
134
3
911-919
Histone Modifications in Stem Cell Development and Their Clinical Implications.
Stem Cell Reports
2020
15
6
1196-1205
Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures.
Epilepsy Res
2020
162
Aspartate aminotransferase and mortality in patients with ischemic heart disease.
Nutr Metab Cardiovasc Dis
2020
30
12
2335-2342
Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms.
Int J Mol Sci
2020
21
21
Continuous, complete and comparable NT-proBNP reference ranges in healthy children.
Clin Chem Lab Med
2020
58
9
1509-1516